Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASIE: Insulin Glargine vs Sitagliptin in T2DM
NCT00751114Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2008
- Primary completion
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 17
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Nov 2008; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00751114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751114.